Literature DB >> 17143769

Hyaluronic acid based materials for intestine tissue engineering: a morphological and biochemical study of cell-material interaction.

A Esposito1, A Mezzogiorno, A Sannino, A De Rosa, D Menditti, V Esposito, L Ambrosio.   

Abstract

A wide number of gastro-intestinal disorders are associated with structural alterations of this district leading to an impaired gastrointestinal function. The study of cell material interactions represents one of the major issues for the development of tissue engineering purposes. Benzyl esters of hyaluronic acid are promising materials because they exhibit good tissue compatibility and are available in various configurations. In this work they have been studied for the possible application of intestinal cell growth and functioning. The preliminary investigation on the morphologic and biochemistry data obtained by monitoring the growth and differentiation of intestinal epithelial cells on two hyaluronic acid benzyl esters is reported. Two types of materials structures were studied: a three dimensional matrix and a macroporous flat sheet membrane. Caco-2 cell line was used: these cells undergo spontaneous enterocytic differentiation after several days in culture. The differentiation status of these cells grown on different materials was used as a parameter of biocompatibility and cell functioning. The status of cell growth and differentiation was monitored by studying cell morphology using scanning electron microscopy. The results obtained were confirmed by biochemical determinations. Although both the configurations of the two polymers exhibited good compatibility with respect to intestinal cells, only the flat sheet membrane proved to induce cell differentiation, leading us to the conclusion that it is a promising substrate for the proposed application.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17143769     DOI: 10.1007/s10856-006-0612-x

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  26 in total

Review 1.  Aspiration and injection therapies for joints.

Authors:  H Ralph Schumacher
Journal:  Arthritis Rheum       Date:  2003-06-15

2.  Long-term follow-up of tissue-engineered intestine after anastomosis to native small bowel.

Authors:  S Kaihara; S S Kim; B S Kim; D Mooney; K Tanaka; J P Vacanti
Journal:  Transplantation       Date:  2000-05-15       Impact factor: 4.939

Review 3.  Intestinal adaptation in short bowel syndrome.

Authors:  Carlo F M Welters; Cornelius H C Dejong; Nicolaas E P Deutz; Erik Heineman
Journal:  ANZ J Surg       Date:  2002-03       Impact factor: 1.872

Review 4.  The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation.

Authors:  M Rousset
Journal:  Biochimie       Date:  1986-09       Impact factor: 4.079

Review 5.  Tissue engineering.

Authors:  R Langer; J P Vacanti
Journal:  Science       Date:  1993-05-14       Impact factor: 47.728

Review 6.  Management of the short bowel syndrome.

Authors:  J S Thompson
Journal:  Gastroenterol Clin North Am       Date:  1994-06       Impact factor: 3.806

Review 7.  Short bowel syndrome.

Authors:  D W Wilmore; M K Robinson
Journal:  World J Surg       Date:  2000-12       Impact factor: 3.352

Review 8.  Short-bowel syndrome in children and adults.

Authors:  J A Vanderhoof; A N Langnas
Journal:  Gastroenterology       Date:  1997-11       Impact factor: 22.682

Review 9.  Nutritional management of short bowel syndrome in adults.

Authors:  Aparna Sundaram; Polyxeni Koutkia; Caroline M Apovian
Journal:  J Clin Gastroenterol       Date:  2002-03       Impact factor: 3.062

Review 10.  Short bowel syndrome: metabolic and surgical management.

Authors:  L K Shanbhogue; J C Molenaar
Journal:  Br J Surg       Date:  1994-04       Impact factor: 6.939

View more
  1 in total

Review 1.  Designing the new generation of intelligent biocompatible carriers for protein and peptide delivery.

Authors:  Angela M Wagner; Margaret P Gran; Nicholas A Peppas
Journal:  Acta Pharm Sin B       Date:  2018-03-02       Impact factor: 11.413

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.